Intelligent Bio Solutions manufactures and sells the Intelligent Fingerprinting Drug Screening System, a portable platform that tests for drugs of abuse using fingerprint sweat. The system consists of single-use, tamper-evident cartridges and a handheld reader that delivers results in under ten minutes. By collecting sweat rather than urine or saliva, the company provides a non-invasive testing method for safety-critical industries including construction, transportation, mining, and manufacturing, as well as for judicial and rehabilitation organizations. Intelligent Bio Solutions employs a razor-and-blades business model, generating recurring revenue from consumable cartridges while selling reusable readers upfront. The company currently serves over 500 customers, primarily in the UK through a direct sales force. Outside the UK, the company reaches customers in Australia and other international markets through third-party agencies and distributors. Growth strategy focuses on expanding the global customer base and entering the US market, which requires obtaining FDA 510(k) clearance. To support this regulatory goal, the company is conducting clinical studies. Intelligent Bio Solutions also intends to expand its detection capabilities to include additional substances and target new sectors such as commercial aviation and law enforcement.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →